Literature DB >> 4584707

Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.

H Poppius, Y Salorinne.   

Abstract

In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4584707      PMCID： PMC1587144          DOI： 10.1136/bmj.4.5885.134

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  5 in total

1.  VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.

Authors:  R E ALTOUNYAN
Journal:  Thorax       Date:  1964-09       Impact factor: 9.139

2.  Inhalation of a new anticholinergic drug, SCH 1000, in asthma and chronic bronchitis: effect on airway resistance, thoracic gas volume, blood gases and exercise-induced asthma.

Authors:  H Poppius; Y Salorinne; A A Viljanen
Journal:  Bull Physiopathol Respir (Nancy)       Date:  1972 May-Jun

3.  A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma.

Authors:  G K Crompton
Journal:  Thorax       Date:  1968-01       Impact factor: 9.139

4.  [Inhalation therapy with atropine derivatives].

Authors:  W T Ulmer
Journal:  Med Klin       Date:  1971-02-26

5.  [On the theory and praxis of total body plethysmography in the lung function analysis].

Authors:  H J Woitowitz; F W Buchheim; R Woitowitz
Journal:  Prax Pneumol       Date:  1967-08
  5 in total
  24 in total

1.  Assessment of a combination of doses of fenoterol and ipratropium suitable for a single metered-dose aerosol.

Authors:  G J Addis; J Barclay; E M Chang
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

2.  Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.

Authors:  R E Ruffin; M T Newhouse
Journal:  Lung       Date:  1978       Impact factor: 2.584

3.  Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction.

Authors:  H Poppius; H Lehti; B Stenius-Aarniala
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

4.  Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.

Authors:  G R Petrie; K N Palmer
Journal:  Br Med J       Date:  1975-02-22

5.  A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma.

Authors:  K C Flint; B Hockley; N M Johnson
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

6.  Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.

Authors:  J A Hughes; M J Tobin; D Bellamy; D C Hutchison
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

7.  Atopy and bronchial reactivity in older patients with cystic fibrosis.

Authors:  M J Tobin; O Maguire; D Reen; E Tempany; M X Fitzgerald
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

Review 8.  Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.

Authors:  D M Newnham
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

9.  Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Authors:  D M Newnham; D P Dhillon; J H Winter; C M Jackson; R A Clark; B J Lipworth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

Review 10.  Chronic obstructive pulmonary disease.

Authors:  N R Anthonisen
Journal:  CMAJ       Date:  1988-03-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.